Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields

Mikko J. Myllymaki, Heikki Kasnanen, Antti O. Kataja, Maija Lahtela-Kakkonen, Susanna M. Saario, Antti Poso, Ari M.P. Koskinen

    Research output: Contribution to journalArticleScientificpeer-review

    19 Citations (Scopus)
    358 Downloads (Pure)

    Fingerprint Dive into the research topics of 'Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields'. Together they form a unique fingerprint.

    Chemical Compounds

    Medicine & Life Sciences